News

A new review in Diabetologia argues that type 2 diabetes in Black Africans differs in some important respects from that found in European populations – findings deserving of further investigation, give...

In the second part of our series on diabetes and under-resourced populations, Dr Susan Aldridge reports on two presentations from the EASD 2022 conference, which explored the particular challenges and soluti...

Under-resourced populations bear the biggest burden of diabetes – and are set to bear the brunt of the alarming rise in diabetes prevalence. In the first of a two-part series posting on Horizons this w...

Analysis of a patient-preference study revealed its efficacy for people with type 2 diabetes at the latest EASD Annual Meeting. Lisa Buckingham reports.

A new paper in Diabetologia does not support the hypothesis that exposure to viral infection in the first year of life may trigger beta cell autoimmunity and type 1 diabetes. Instead, the study finds that it...

Tackling sugar intake is a key part of reducing the prevalence of obesity and diabetes, but how best to do it? Evidence for the taxation of sugar-sweetened beverages was presented at the recent EASD Annual M...

Depression is more common in those diagnosed with type 2 diabetes under the age of 40 than those diagnosed later in life. These findings from UK and USA data, reported in a recent issue of Diabetologia, high...

The epigenome plays a crucial role in regulating gene expression, cell differentiation and X-chromosome inactivation – and can contribute to disease when dysfunctional. In her new module for EASD e-Lea...

Remission of type 2 diabetes is now seen as a real alternative to a lifetime of medication and worry about complications. The down side is that it may not last, and the issue of relapse was in the spotlight ...

A fascinating insight into diabetes stigma and how it can be tackled was presented at the recent EASD conference. Lisa Buckingham reports.

As the world looks towards urgent discussions at the COP27 meeting, we need to acknowledge the significant impact healthcare makes to climate change through the generation of waste. In recognition of this, t...

Accreditation for 14 EASD e-Learning modules by the Federation of the Royal Colleges of Physicians of the UK (RCP) mean that learners now have even more opportunities to earn continuous professional developm...

Being able to identify early the patients who may struggle more with a diabetes diagnosis is increasingly seen as a key aspect of care. Work to further our understanding of this was presented at the recent E...

Online peer support was highlighted at EASD 2022, as diabetes advocates from around the world presented some of the work of the #dedoc° Diabetes Online Community and discussed their response to the pande...

The importance of maintaining normal glycaemia in type 2 diabetes from the day of diagnosis was underlined by the presentation of long-term findings from the UK Prospective Diabetes Study (UKPDS) at EASD 202...

A new study reported in a recent issue of Diabetologia identifies children in the general population in Germany who have presymptomatic type 1 diabetes and estimates their risk of going on to develop clinica...

Research that furthers our understanding of the health benefits of high-intensity interval training (HIIT) was presented at the 58th EASD Annual Meeting. Lisa Buckingham reports.

Learner feedback helps to ensure that the EASD e-Learning programme is up to date, evidence based and meets the needs of learners. It is also important that learners know their feedback is taken seriously. S...

As rates of type 2 diabetes continue to rise around the world, prevention of the condition has never been more important. A review in a recent issue of Diabetologia looks at the opportunities and challenges ...

SGLT-2 inhibitors are now recommended as first-line therapy for people with type 2 diabetes who have had a previous cardiovascular event. However, there are concerns over a few safety issues associated with ...

The European Association for the Study of Diabetes (EASD) welcomed delegates to Stockholm in September, with its first in-person conference for three years. Dr Susan Aldridge reports.